CompletedPhase 4NCT04525729

Rituximab and RASi in Patients with IgAN

Studying IgA Nephropathy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nan Chen,MD
Principal Investigator
Jingyuan Xie
Ruijin Hospital
Intervention
Rituximab(drug)
Enrollment
116 enrolled
Eligibility
18-75 years · All sexes
Timeline
2020 – 2024

Study locations (1)

Collaborators

Dongfang Hospital Affiliated to Tongji University · Shanghai Pudong New Area People's Hospital · Ruijin Hospital North Shanghai Jiao Tong University School of Medicine · Ningbo Municipal Yinzhou District No.2 Hospital · Third Affiliated Hospital, Sun Yat-Sen University · Xiamen Hong'ai Hospital · Sir Run Run Shaw Hospital · Tongji Hospital · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04525729 on ClinicalTrials.gov

Other trials for IgA Nephropathy

Additional recruiting or active studies for the same condition.

See all trials for IgA Nephropathy →

← Back to all trials